Temasek led a funding round that expanded the UC-RNT Fund-backed health and wellness services platform's overall financing to approximately $390m.

CureFit, an India-based wellness services app developer backed by UC-RNT Fund, has received Rs 8.32bn ($109m) in funding from investors including consumer goods producer Unilever, Entrackr has reported, citing a regulatory filing.
Singaporean state-owned Temasek invested $71m to lead the round, which also featured Accel, Chiratae Ventures, GableHorn Investments, Castle Investments, Epiq Capital, Pathiti Investment Trust and Ascent Capital.
Unilever’s corporate venturing subsidiary, Unilever Ventures, supplied $2.8m for the round.
CureFit offers a unified health and wellness…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?